Copyright
©The Author(s) 2018.
World J Diabetes. Jan 15, 2018; 9(1): 1-24
Published online Jan 15, 2018. doi: 10.4239/wjd.v9.i1.1
Published online Jan 15, 2018. doi: 10.4239/wjd.v9.i1.1
Table 1 Cardiac autonomic neuropathy in type 1 and type 2 diabetes mellitus: Differences in relation to risk factors and natural history[21]
Risk factors | Type 1 DM | Type 2 DM |
Age | + | + |
Gender (female) | + | - |
Obesity | - | + |
Hyperinsulinemia | NA | + |
Duration of DM | ++ | ++ |
Smoking | + | + |
HbA1c | ++ | ++ |
Hypertension | ++ | + |
Retinopathy | ++ | + |
Hypertriglyceridemia | + | + |
Classical DPN | ++ | ++ |
Microalbuminuria | ++ | ++ |
Dyslipoproteinemia (> LDL and < HDL | + | (+) |
Prevalence at diagnosis of DM | 7.70% | 5% |
Prevalence after 10 yr | 38% | 65% |
Prevalence (random) | 25% | 34% |
Cardiovascular system | Peripheral vascular function |
Perioperative unstability | ↑ Peripheral blood flow and warm skin |
Resting tachycardia | ↑ Arteriovenous shunting and swollen veins |
Loss of reflex heart rate variations | ↑ Venous pressure |
Hypertension | Leg and foot oedema |
Exercise intolerance | Loss of protective cutaneous vasomotor reflexes |
Orthostatic hypotension | Loss of venoarteriolar reflex with microvascular damage |
Postprandial hypotension | ↑ Transcapillary leakage of macromolecules |
Silent myocardial ischaemia | ↑ Medial arterial calcification |
Left ventricular dysfunction and hypertrophy | - |
QT interval prolongation | - |
Impaired baroreflex sensitivity | - |
Non-dipping, reverse dipping | - |
Sympathovagal imbalance | - |
Dysregulation of cerebral circulation | - |
↓ Sympathetically mediated vasodilation of coronary vessels | - |
↑ Arterial stiffness | - |
Table 3 Symptoms and signs associated with diabetic cardiovascular autonomic neuropathy[39]
Cardiovascular autonomic neuropathy | |
Resting tachycardia | |
Abnormal blood pressure regulation | Nondipping |
Reverse dipping | |
Orthostatic hypotension (all with standing) | Light-headedness |
Weakness | |
Faintness | |
Visual impairment | |
Syncope | |
Orthostatic tachycardia or bradycardia and chronotropic incompetence (all with standing) | Light-headedness |
Weakness | |
Faintness | |
Dizziness | |
Visual impairment | |
Syncope | |
Exercise intolerance |
Test | Technique | Normal response and values |
Beat-to-beat HRV | With the patient at rest and supine, heart rate is monitored by ECG while the patient breathes in and out at 6 breaths per minute, paced by a metronome or similar device | A difference in HR of > 15 beats per minute is normal and < 10 beats per minute is abnormal. The lowest normal value for the expiration-to inspiration ratio of the R-R interval decreases with age: age 20-24 yr, 1.17; 25-29, 1.15; 30-34, 1.13; 35-39, 1.12; 40-44, 1.10; 45-49, 1.08; 50-54, 1.07; 55-59, 1.06; 60-64, 1.04; 65-69, 1.03; and 70-75, 1.02 |
Heart rate response to standing | During continuous ECG monitoring, the R-R interval is measured at beats 15 and 30 after standing | Normally, a tachycardia is followed by reflex bradycardia. The 30:15 ratio should be > 1.03, borderline 1.01-1.03 |
Heart rate response to the valsalva maneuver | The subject forcibly exhales into the mouthpiece of a manometer to 40 mmHg for 15 s during ECG monitoring | Healthy subjects develop tachycardia and peripheral vasoconstriction during strain and an overshoot bradycardia and rise in BP with release. The normal ratio of longest R-R to shortest R-R is > 1.2, borderline 1.11-1.2 |
Systolic blood pressure response to standing | Systolic BP is measured in the supine subject. The patient stands and the systolic BP is measured after 2 min | Normal response is a fall of < 10 mmHg, borderline fall is a fall of 10-29 mmHg and abnormal fall is a decrease of > 30 mmHg |
Diastolic blood pressure response to isometric exercise | The subject squeezes a handgrip dynamometer to establish a maximum. Grip is then squeezed at 30% maximum for 5 min | The normal response for diastolic BP is a rise of > 16 mmHg in the other arm, borderline 11-15 mmHg |
Table 5 Normal, borderline and abnormal values in tests of cardiovascular autonomic function[27]
Normal | Borderline | Abnormal | |
Tests reflecting mainly parasympathetic function | |||
Heart rate response to Valsalva Manoeuvre (Valsalva ratio) | ≥ 1.21 | 1.11–1.20 | ≤ 1.10 |
Heart rate (R-R interval) variation | ≥ 15 beats/min | 11–14 beats/min | ≤ 10 beats/min |
During deep breathing (maximum-minimum heart rate) immediate heart rate response to standing (30:15 ratio) | ≥ 1.04 | 1.01-1.03 | ≤ 1.00 |
Tests reflecting mainly sympathetic function | |||
Blood pressure response to standing (fall in systolic blood mmHg mmHg mmHg pressure) | ≤ 10 | 11–29 | ≥ 30 |
Blood pressure response to sustained handgrip (increase in diastolic blood pressure | ≥ 16 mmHg | 11–15 mmHg | ≤ 10 mmHg |
Symptoms | Signs/diagnostic tests | Differential workup | |
Resting tachycardia | Palpitations could be asymptomatic | Clinical exam: Resting heart rate > 100 bpm | Anemia hyperthyroidism fever |
CVD (atrial fibrillation, | |||
flutter, other) | |||
Dehydration | |||
Adrenal insufficiency | |||
Some medications | |||
Smoking, alcohol, caffeine | |||
Recreational drugs (cocaine, amphetamines, methamphetamine, mephedrone) | |||
Orthostatic hypotension | Light-headedness | Clinical exam: A reduction of > 20 mmHg in the systolic blood pressure or > 10 mmHg in diastolic blood pressure | Adrenal insufficiency |
Weakness | Intravascular volume depletion | ||
Faintness | Blood loss/acute anemia | ||
Visual impairment | Dehydration | ||
Syncope | Pregnancy/postpartum | ||
CVD | |||
Alcohol | |||
Medication | |||
Antiadrenergics | |||
Antianginals | |||
Antiarrhythmics | |||
Anticholinergics | |||
Diuretics | |||
ACE inhibitors/angiotensin receptor blocker | |||
Narcotics | |||
Neuroleptics | |||
Sedatives |
Table 7 Differential diagnosis of diabetic neuropathies[39]
Metabolic disease | Thyroid disease (common) |
Renal disease | |
Systemic disease | Systemic vasculitis |
Nonsystemic vasculitis | |
Paraproteinemia (common) | |
Amyloidosis | |
Infectious | Human immunodeficiency virus |
Hepatitis B | |
Lyme | |
Inflammatory | Chronic inflammatory demyelinating polyradiculoneuropathy |
Nutritional | B12 |
Postgastroplasty | |
Pyridoxine | |
Thiamine | |
Tocopherol | |
Industrial agents, drugs, and metals | |
Industrial agents | |
Acrylamide | |
Organophosphorous agents | |
Drugs | Alcohol |
Amiodarone | |
Colchicine | |
Dapsone | |
Vinka alkaloids | |
Metals | Platinum |
Taxol | |
Arsenic | |
Mercury | |
Hereditary | Hereditary motor, sensory, and autonomic neuropathies |
- Citation: Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World J Diabetes 2018; 9(1): 1-24
- URL: https://www.wjgnet.com/1948-9358/full/v9/i1/1.htm
- DOI: https://dx.doi.org/10.4239/wjd.v9.i1.1